Frank van Bel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Frank van Bel has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Floris Groenendaal
Department of Neonatology, Wilhelmina Children's Hospital and Brain Center Rudolph Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
3 shared publicationsThomas Alderliesten
2 shared publicationsCorine Koopman-Esseboom
Department of Neonatology, Wilhelmina Children's Hospital and Brain Center Rudolph Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
1 shared publication- Corline E. J. Parmentier
Department of Neonatology Wilhelmina Children's Hospital Utrecht and Utrecht Brain Center, University Medical Center Utrecht, Utrecht University Utrecht the Netherlands
1 shared publication - Daniel C. Vijlbrief
Neonatal Intensive Care Unit, University Medical Centre Utrecht
1 shared publication Daniel Vijlbrief
Department of Neonatology, Wilhelmina Children's Hospital and Brain Center Rudolph Magnus, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 2 September 2025
- Published by S. Karger AG in Neonatology
- Vol. 122 (6) , 741-750
Cerebral Oxygenation Pattern during Therapeutic Hypothermia after Perinatal Asphyxia: A Single Center Cohort Study
Introduction: Investigation the association between cerebral oxygenation and short-term adverse outcome in asphyxiated infants with hypoxic-ischemic encephalopathy (HIE) during therapeutic hypothermia (TH). Methods: Near infrared spectroscopic-derived cerebral oxygen saturation (rScO2) pattern during first 4 days was compared to early brain MRI (4–10 days) using the Weeke score to define MRI-derived brain injury of infants with GA >35 weeks treated with TH within 6 h between 2010 and 2023. Weeke scores of >9 were considered adverse short-term outcome. Infants with congenital abnormalities, chromosomal disorders, or on ECMO were excluded. Results: 292 infants (mean ± 1 SD: GA 39.4 ± 1.9 weeks; BW 3,442 ± 621 g; median [IQR] 5-min Apgar score 4 [3]) were eligible. According to the Sarnat staging, HIE was mild, moderate, or severe in 77, 148, and 67 infants. Adverse short-term outcome/death occurred in 0, 39 (26.4%), and 67 (100%) infants in mild, moderate, and severe HIE groups. Severe HIE infants had higher rScO2 values compared to moderate or mild HIE infants. Mixed model analysis showed an association between rScO2 (dependent variable), time after birth, adverse short-term outcome, and inhaled nitric oxide. Logistic regression showed that adverse outcome had a positive association with rScO2 and first lactate levels. Discussion: High cerebral oxygen saturation during TH is associated with adverse short-term outcome. This knowledge may contribute to early counseling and decision-making. Combination with early blood lactate levels strengthened this association. Simultaneous NO-ventilation may confound this association.
- 2 September 2025
- Published by S. Karger AG in Neonatology
- Vol. 122 (6) , 741-750
Open AccessCerebral Oxygenation Pattern during Therapeutic Hypothermia after Perinatal Asphyxia: A Single Center Cohort Study
Introduction: Investigation the association between cerebral oxygenation and short-term adverse outcome in asphyxiated infants with hypoxic-ischemic encephalopathy (HIE) during therapeutic hypothermia (TH). Methods: Near infrared spectroscopic-derived cerebral oxygen saturation (rScO2) pattern during first 4 days was compared to early brain MRI (4–10 days) using the Weeke score to define MRI-derived brain injury of infants with GA >35 weeks treated with TH within 6 h between 2010 and 2023. Weeke scores of >9 were considered adverse short-term outcome. Infants with congenital abnormalities, chromosomal disorders, or on ECMO were excluded. Results: 292 infants (mean ± 1 SD: GA 39.4 ± 1.9 weeks; BW 3,442 ± 621 g; median [IQR] 5-min Apgar score 4 [3]) were eligible. According to the Sarnat staging, HIE was mild, moderate, or severe in 77, 148, and 67 infants. Adverse short-term outcome/death occurred in 0, 39 (26.4%), and 67 (100%) infants in mild, moderate, and severe HIE groups. Severe HIE infants had higher rScO2 values compared to moderate or mild HIE infants. Mixed model analysis showed an association between rScO2 (dependent variable), time after birth, adverse short-term outcome, and inhaled nitric oxide. Logistic regression showed that adverse outcome had a positive association with rScO2 and first lactate levels. Discussion: High cerebral oxygen saturation during TH is associated with adverse short-term outcome. This knowledge may contribute to early counseling and decision-making. Combination with early blood lactate levels strengthened this association. Simultaneous NO-ventilation may confound this association.
- Open Access
- 12 October 2022
- Published by Elsevier in The Journal of Pediatrics
- Vol. 254, 25-32
Delayed Surgical Closure of the Patent Ductus Arteriosus: Does the Brain Pay the Price?
- 12 October 2022
- Published by Elsevier in The Journal of Pediatrics
- Vol. 254, 25-32
Open AccessDelayed Surgical Closure of the Patent Ductus Arteriosus: Does the Brain Pay the Price?
- 1 May 2020
- Published by AME Publishing Company in Pediatric Medicine
- Vol. 3, 3
Birth asphyxia-induced brain damage: the long road to optimal reduction and prevention!
Moderate hypothermia (HT) is the only established therapy to reduce birth asphyxia-induced brain injury in (near) term neonates, but it is conceivable that pharmacological add-on therapy during or after HT can further reduce brain damage. This paper summarizes neuroprotective interventions with drugs that have possible potential to do so. We finally discuss the potential role of autologous and allogenic mesenchymal stem cell therapy for the repair of birth asphyxia-related brain injury.
- 1 May 2020
- Published by AME Publishing Company in Pediatric Medicine
- Vol. 3, 3
Birth asphyxia-induced brain damage: the long road to optimal reduction and prevention!
Moderate hypothermia (HT) is the only established therapy to reduce birth asphyxia-induced brain injury in (near) term neonates, but it is conceivable that pharmacological add-on therapy during or after HT can further reduce brain damage. This paper summarizes neuroprotective interventions with drugs that have possible potential to do so. We finally discuss the potential role of autologous and allogenic mesenchymal stem cell therapy for the repair of birth asphyxia-related brain injury.
- 1 April 2016
- Published by Elsevier in Seminars in Perinatology
- Vol. 40 (3) , 152-159
Drugs for neuroprotection after birth asphyxia: Pharmacologic adjuncts to hypothermia
- 1 April 2016
- Published by Elsevier in Seminars in Perinatology
- Vol. 40 (3) , 152-159
Drugs for neuroprotection after birth asphyxia: Pharmacologic adjuncts to hypothermia